NasdaqCM - Delayed Quote USD

Sangamo Therapeutics, Inc. (SGMO)

0.4985
+0.0285
+(6.06%)
At close: 4:00:01 PM EDT
0.4980
-0.00
(-0.10%)
After hours: 7:29:30 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
63,756
57,800
176,232
111,299
110,701
Operating Expense
144,655
156,248
295,224
312,580
294,038
Operating Income
-80,899
-98,448
-118,992
-201,281
-183,337
Net Non Operating Interest Income Expense
5,719
5,861
11,102
9,432
5,346
Other Income Expense
-4,415
-5,521
-155,013
--
--
Pretax Income
-79,595
-98,108
-262,903
-191,849
-177,991
Tax Provision
-146
-167
-5,072
429
306
Net Income Common Stockholders
-79,449
-97,941
-257,831
-192,278
-178,286
Diluted NI Available to Com Stockholders
-79,449
-97,941
-257,831
-192,278
-178,286
Basic EPS
-0.36
-0.49
-1.48
-1.25
-1.23
Diluted EPS
-0.36
-0.49
-1.48
-1.25
-1.23
Basic Average Shares
211,680.7500
201,699
174,444
154,345
144,568
Diluted Average Shares
211,680.7500
201,699
174,444
154,345
144,568
Total Operating Income as Reported
-82,071
-103,969
-274,005
-201,281
-183,337
Total Expenses
144,655
156,248
295,224
312,580
294,038
Net Income from Continuing & Discontinued Operation
-79,449
-97,941
-257,831
-192,278
-178,286
Normalized Income
-78,279.1498
-92,429.3979
-105,808.5552
-192,278
-178,286
Interest Income
5,719
5,861
11,102
9,432
5,346
Net Interest Income
5,719
5,861
11,102
9,432
5,346
EBIT
-80,899
-98,448
-118,992
-201,281
-183,337
EBITDA
-72,140
-89,087
-96,800
-180,719
-165,699
Reconciled Depreciation
8,759
9,361
22,192
20,562
17,638
Net Income from Continuing Operation Net Minority Interest
-79,449
-97,941
-257,831
-192,278
-178,286
Total Unusual Items Excluding Goodwill
-1,172
-5,521
-155,013
0
0
Total Unusual Items
-1,172
-5,521
-155,013
0
0
Normalized EBITDA
-70,968
-83,566
58,213
-180,719
-165,699
Tax Rate for Calcs
0
0
0
0.0002
0.0003
Tax Effect of Unusual Items
-2.1498
-9.3979
-2,990.5552
0
0
12/31/2021 - 4/6/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XLO Xilio Therapeutics, Inc.
0.8800
+2.40%
 
CTMX CytomX Therapeutics, Inc.
2.1300
+4.93%
 
AFMD Affimed N.V.
0.1815
-34.95%
 
BLUE bluebird bio, Inc.
4.9800
+0.20%
 
INZY Inozyme Pharma, Inc.
3.9900
+1.01%
 
CABA Cabaletta Bio, Inc.
1.9200
-5.42%
 
CNSP CNS Pharmaceuticals, Inc.
1.2900
+0.78%
 
ABP Abpro Holdings, Inc.
0.2720
+18.26%
 
NCNA NuCana plc
0.0482
+10.05%
 
HCWB HCW Biologics Inc.
8.57
-4.25%